Search results
Dr Himanshu Brahmbhatt Co-Founder and Joint-CEO. Co-founded EnGeneIC Pty Ltd in 2001 and built it from the concept stage to a company based in Australia and USA, a small scale manufacturing plant in Sydney and now a clinical stage biopharmaceutical company.
Himanshu Brahmbhatt is known for Rog (2005), Vishwasghaat (1996) and Dil Hai Ki Manta Nahin (1991).
- Himanshu Brahmbhatt
Jan 31, 2022 · Australian biotechnology company EnGeneIC has cancer and COVID-19 squarely in its sights. Armed with world-first cyto-immunotherapy, Co-Founders and Joint CEOs Jennifer MacDiarmid and Himanshu Brahmbhatt believe effective treatment may be closer than ever.
Himanshu Brahmbhatt. Co-Founder, Joint-CEO & Director at EnGeneIC. Show contact. Himanshu graduated with an M.Sc. from the MS University (Baroda, India) and Ph.D from University of Adelaide (Australia). He did his post-doctoral research at the Geneva Medical Centre (Switzerland) and The National Centre for Research in Biotechnology (Germany).
Nov 30, 2021 · EngeneIC joint Chief Executive, Dr Himanshu Brahmbhatt, believes it will be effective. "These high-affinity antibodies are capable of locking on in such a way that it hangs on — no matter what ...
Armed with world-first cyto-immunotherapy, Co-Founders and Joint CEOs Jennifer MacDiarmid and Himanshu Brahmbhatt believe effective treatment may be closer than ever. The battle against cancer has brought out the best in the biopharmaceutical industry.
May 14, 2019 · Himanshu Brahmbhatt, co-CEO of EnGeneIC, a biopharma company, talks about the company’s development of a first-in-class cyto-immunotherapy platform for targeted delivery of chemotherapeutics directly into tumors but limits harm to any healthy cells.
